Alembic Pharmaceuticals Ltd Annually Results

Gross Sales

6,672.08

6,228.63

5,652.62

5,305.79

5,393.13

Excise Duty

0

0

0

0

0

Net Sales

6,672.08

6,228.63

5,652.62

5,305.79

5,393.13

Other Operating Income

0

0

0

0

0

Other Income

56.3

28.31

2.74

55.74

87.29

Total Income

6,728.38

6,256.94

5,655.36

5,361.53

5,480.42

Total Expenditure

5,663.85

5,296.25

4,975.17

4,431.63

3,912.85

PBIDT

1,064.53

960.69

680.19

929.9

1,567.57

Interest

78.77

56.19

50.17

17.73

16.02

PBDT

985.76

904.5

630.02

912.17

1,551.55

Depreciation

278.58

272.67

275.43

286.78

183.47

Minority Interest Before NP

0

0

0

0

0

Tax

122.18

62.06

3.41

127.93

262.88

Deferred Tax

2.99

-46.05

9.19

-23.48

-9.56

Reported Profit After Tax

582.01

615.82

341.99

520.94

1,114.76

Minority Interest After NP

-1.41

0

0

0

-31.61

Net Profit after Minority Interest

583.42

615.82

341.99

520.94

1,178.11

Extra-ordinary Items

10.6

0

0

0

0

Adjusted Profit After Extra-ordinary item

572.82

615.82

341.99

520.94

1,178.11

EPS (Unit Curr.)

29.68

31.33

17.4

26.5

60.81

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

550

550

400

500

700

Equity

39.31

39.31

39.31

39.31

39.31

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

15.95

15.42

12.03

17.52

29.06

PBDTM(%)

14.77

14.52

11.14

17.19

28.76

PATM(%)

8.72

9.88

6.05

9.81

20.67